Production (Stage)
Context Therapeutics Inc.
CNTX
$0.6095
-$0.0199-3.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 785.62% | 553.50% | 291.21% | 303.92% | -66.11% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 234.77% | 116.99% | -1.87% | -54.83% | -55.14% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 740.05% | 510.05% | 274.70% | 270.63% | -65.38% |
|
|
|||||
| Total Current Assets | 740.05% | 510.05% | 274.70% | 270.63% | -65.38% |
| Net Property, Plant & Equipment | 1,705.38% | 1,389.03% | 1,330.94% | -63.76% | -76.06% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 741.19% | 510.90% | 275.53% | 269.96% | -65.43% |
|
|
|||||
| Total Accounts Payable | -51.05% | -39.06% | -43.72% | -48.65% | 69.00% |
| Total Accrued Expenses | 29.30% | 29.32% | -59.19% | -61.28% | -71.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 464.23% | 485.88% | 56.99% | -51.97% | -69.00% |
| Total Other Current Liabilities | 464.23% | 485.88% | 56.99% | -51.97% | -69.00% |
| Total Current Liabilities | -27.15% | -34.43% | -49.35% | -57.30% | -19.33% |
|
|
|||||
| Total Current Liabilities | -27.15% | -34.43% | -49.35% | -57.30% | -19.33% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -23.98% | -31.76% | -46.30% | -57.30% | -19.33% |
|
|
|||||
| Common Stock & APIC | 137.43% | 137.78% | 120.03% | 120.47% | 1.31% |
| Retained Earnings | -38.53% | -39.27% | -49.20% | -33.51% | -42.31% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 977.59% | 702.51% | 356.12% | 321.19% | -70.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 977.59% | 702.51% | 356.12% | 321.19% | -70.61% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 977.59% | 702.51% | 356.12% | 321.19% | -70.61% |
|
|
|||||